TickerFacts.

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Operating Income

Annual figures by period end, from SEC filings.

2008-12-31: -$27.84M2009-12-31: -$48.11M2010-12-31: -$44.07M2011-12-31: -$54.82M2012-12-31: -$129.46M2013-12-31: -$92.94M2014-12-31: -$404.98M2015-12-31: -$296.01M2016-12-31: -$424.59M2017-12-31: -$500.09M2018-12-31: -$814.67M2019-12-31: -$939.43M2020-12-31: -$828.44M2021-12-31: -$708.65M2022-12-31: -$785.07M2023-12-31: -$282.18M2024-12-31: -$176.88M2025-12-31: $501.58M$501.58M
2008-12-31Operating Income (USD)2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$501.58M—2026-02-12From 2025-01-01
2024-12-31-$176.88M—2026-02-12From 2024-01-01
2023-12-31-$282.18M—2026-02-12From 2023-01-01
2022-12-31-$785.07M—2025-02-13From 2022-01-01
2021-12-31-$708.65M—2024-02-15From 2021-01-01
2020-12-31-$828.44M—2023-02-23From 2020-01-01
2019-12-31-$939.43M—2022-02-10From 2019-01-01
2018-12-31-$814.67M—2021-02-11From 2018-01-01
2017-12-31-$500.09M—2020-02-13From 2017-01-01
2016-12-31-$424.59M—2019-02-14From 2016-01-01
2015-12-31-$296.01M—2018-02-15From 2015-01-01
2014-12-31-$404.98M—2017-02-15From 2014-01-01
2013-12-31-$92.94M—2016-02-12From 2013-01-01
2012-12-31-$129.46M—2015-02-13From 2012-01-01
2011-12-31-$54.82M—2014-02-20From 2011-01-01
2010-12-31-$44.07M—2013-02-19From 2010-01-01
2009-12-31-$48.11M—2012-02-13From 2009-01-01
2008-12-31-$27.84M—2011-02-18From 2008-01-01